California 2023-2024 Regular Session

California Assembly Bill AB1233

Introduced
2/16/23  
Introduced
2/16/23  
Refer
3/16/23  
Refer
3/16/23  
Report Pass
3/16/23  
Report Pass
3/16/23  
Refer
3/20/23  
Refer
3/20/23  
Report Pass
3/23/23  
Report Pass
3/23/23  
Refer
3/27/23  
Report Pass
3/29/23  
Report Pass
3/29/23  
Refer
3/29/23  
Report Pass
4/19/23  
Report Pass
4/19/23  
Engrossed
4/27/23  
Engrossed
4/27/23  
Refer
4/27/23  
Refer
5/10/23  
Refer
5/10/23  
Report Pass
6/7/23  
Report Pass
6/7/23  
Refer
6/7/23  
Refer
6/26/23  
Report Pass
9/1/23  
Report Pass
9/1/23  
Enrolled
9/12/23  
Enrolled
9/12/23  
Chaptered
10/8/23  
Passed
10/8/23  

Caption

Substance abuse: Naloxone Distribution Project: tribal governments.

Impact

The legislation is designed to enhance the accessibility of opioid antagonists in tribal jurisdictions, with a special emphasis on educating tribal leaders about available resources. Additionally, the Department is required to offer technical assistance to tribal entities seeking naloxone kits. The program is anticipated to yield significant health benefits and is expected to lead to a reduction in opioid overdoses and fatalities among Native populations. Following its implementation, the Department must report its progress on an annual basis to state legislative bodies, creating accountability and ensuring that program effectiveness can be evaluated adequately.

Summary

Assembly Bill No. 1233, introduced by Waldron, focuses on addressing the critical issue of substance abuse, particularly within tribal communities in California. The bill mandates the State Department of Health Care Services to carry out outreach programs specifically aimed at tribal governments to inform them about the availability of naloxone hydrochloride and other opioid antagonists. This initiative aims to reduce the rising rate of opioid-related overdose deaths by providing essential resources to understand and access these life-saving medications. The outreach initiative also addresses the unique challenges faced by Native American communities with respect to substance use and associated health issues.

Sentiment

Overall, sentiments around AB 1233 appear to be supportive, particularly among advocates for public health and substance abuse prevention. Stakeholders recognize the necessity of such programs in combatting opioid addiction and the particular need for attention within tribal communities. However, some discussions may arise regarding the adequacy of government outreach and support for these communities, emphasizing the importance of tailored programs that meet specific local needs.

Contention

While the bill is generally well-received, potential contention could arise surrounding resource allocation and the effectiveness of outreach efforts. Critics may question whether the support provided through the Naloxone Distribution Project will reach all tribal governments effectively, given the unique geographical and cultural differences within tribal communities. Furthermore, the bill's expiration in March 2027 could be a point of debate, encouraging discussions around long-term funding and sustainability of the initiative beyond its immediate provisions.

Companion Bills

No companion bills found.

Similar Bills

CA AB1037

Public health: substance use disorder.

CA SB234

Opioid antagonists: stadiums, concert venues, and amusement parks.

IL SB3350

FENTANYL TEST STRIPS

CA AB915

Pupil health: drug education: opioid overdose training program.

CA AB1915

Pupil health: drug education: opioid overdose training program.

CA SB997

Pupil health: opioid antagonists and fentanyl test strips.

CA SB472

Pupil health: opioid overdose reversal medication.